SpyGlass AMEA Registry

NCT02281019 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 526

Last updated 2019-07-10

No results posted yet for this study

Summary

The purpose of this study is to document indications for cholangioscopy and clinical utility of the SpyGlass Direct Visualization System (DVS) throughout the AMEA (Asia, Middle-East, Africa) region when used per standard of practice.

Conditions

  • Biliary Stricture
  • Biliary Obstruction Due to Common Bile Duct Stone
  • Periampullary Tumor
  • Hemobilia

Interventions

PROCEDURE

ERCP (Endoscopic Retrograde Cholangiopancreatography)

ERCP procedure will be performed to visualize bile ducts.

DEVICE

SpyGlass DVS and SpyGlass Digital Simple (DS)

Cholangioscopy using SpyGlass™ DVS or SpyGlass DS will be performed post ERCP for direct viewing of the bile ducts. What is seen during the procedure will determine a course of treatment. Among the options are biopsies taken, stones treated/removed, or a stent placed

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Benedict Devereaux · Royal Brisbane and Women's Hospital

  • James Lau · Prince of Wales Hospital

  • Randhir Sud · Institute of Digestive & Hepatobiliary Sciences

  • Saad Niaz · Civil Hospital Karachi

  • Abdulrahman Aljebreen · King Khalid University Hospital

  • Ang Tiing Leong · Changi General Hospital Pte Ltd.

  • Jorg Reichenberger · Netcare Unitas Hospital

  • Jong Moon · Soon Chun Hyang University

  • Rungsun Rerknimitr · King Chulalongkorn Memorial Hospital

  • Ichiro Yasuda · Teikyo University Mizonokuchi Hospital

  • Arthur J. Kaffes · Royal Prince Alfred Hospital, Sydney, Australia

  • Nam Q. Nguyen · Royal Adelaide Hospital

  • Amit Maydeo · Baldota Institute of Digestive Sciences

  • Mohan Ramchandani · Asian Institute of Gastroenterology

  • Mahesh Goenka · Apollo Gleneagles Hospital

  • Professor R. Kochhar · Postgraduate Institute of Medical Education & Research

  • Takao Itoi · Tokyo Medical University

  • Masayuki Kitano · Kinki University School of Medicine

  • Jong K. Lee · Samsung Medical Center

  • Dongwan Seo · Asan Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-15
Primary Completion
2016-09-30
Completion
2016-10-18

Countries

  • Australia
  • Hong Kong
  • India
  • Japan
  • Pakistan
  • Saudi Arabia
  • Singapore
  • South Africa
  • South Korea
  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02281019 on ClinicalTrials.gov